Literature DB >> 22381601

Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial.

Meena Khandelwal1, Eric Chang, Clare Hansen, Krystal Hunter, Barry Milcarek.   

Abstract

OBJECTIVE: We sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) is similar with 12- vs 24-hour dosing interval of betamethasone. STUDY
DESIGN: This was a prospective, randomized, open, noninferiority trial. Mothers (n = 228) with a singleton or multiple pregnancies (fetuses = 260), between gestational age of 23-34 weeks, at risk for preterm delivery, received standard 2 doses of betamethasone either 12 or 24 hours apart in 2:1 ratio, respectively.
RESULTS: Incidence of RDS was similar in the 2 cohorts (36.5% vs 37.3%; P = not significant). Women unable to receive the complete course of corticosteroids with the 24-hour interval can be reduced by half with the 12-hour interval. However, increased incidence of necrotizing enterocolitis was seen with 12-hour dosing (6.2% vs 0%; P = .03).
CONCLUSION: The 12-hour dosing interval is equivalent to the 24-hour dosing interval for prevention of RDS in neonates of mothers delivering prematurely. A larger multicenter study is needed to confirm our findings.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381601     DOI: 10.1016/j.ajog.2012.01.025

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

Review 2.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Devender Roberts; Julie Brown; Nancy Medley; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

Review 3.  Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.

Authors:  Myfanwy J Williams; Jenny A Ramson; Fiona C Brownfoot
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

4.  Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor.

Authors:  Hatav Ghasemi Tehrani; Behnaz Khani; Zahra Komrani
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

5.  Antenatal Betamethasone Every 12 Hours in Imminent Preterm Labour.

Authors:  Natalia Saldaña-García; María Gracia Espinosa-Fernández; Jose David Martínez-Pajares; Elías Tapia-Moreno; María Moreno-Samos; Celia Cuenca-Marín; Francisca Rius-Díaz; Tomás Sánchez-Tamayo
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

6.  Administration of Antenatal Corticosteroids: Current State of Knowledge.

Authors:  Richard Berger; Ioannis Kyvernitakis; Holger Maul
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-01-11       Impact factor: 2.915

7.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Emma McGoldrick; Fiona Stewart; Roses Parker; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2020-12-25

Review 8.  Antenatal steroids: can we optimize the dose?

Authors:  Ewa Romejko-Wolniewicz; Justyna Teliga-Czajkowska; Krzysztof Czajkowski
Journal:  Curr Opin Obstet Gynecol       Date:  2014-04       Impact factor: 1.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.